Cambridge Biostability Ltd.
www.biostability.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Cambridge Biostability Ltd.
Lipoxen awarded PATH funding for malaria study
Bookmark
Lipoxen has received funding from the PATH Malaria Vaccine Initiative for a feasibility study to test whether its ImuXen technology will enhance the performance of malaria vaccine candidates. The amount was not disclosed.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
Advertisement
Advertisement
Cambridge Biostability Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice